• 1472 Citations
  • 23 h-Index
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Britta Will is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 18 Similar Profiles
Myelodysplastic Syndromes Medicine & Life Sciences
Acute Myeloid Leukemia Medicine & Life Sciences
Stem Cells Medicine & Life Sciences
Hematopoietic Stem Cells Medicine & Life Sciences
Thrombopoietin Receptors Medicine & Life Sciences
Stem cells Chemical Compounds
Leukemia Medicine & Life Sciences
Hematopoiesis Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Grants 2011 2023

Cell Aging
Stem Cells
Hematopoietic Stem Cells
Neoplastic Stem Cells
Hematopoietic Stem Cells
Bone Marrow
Cell Aging
AT Rich Sequence
Carrier Proteins
Hematopoietic Stem Cells

Publications 2007 2019

  • 1472 Citations
  • 23 h-Index
  • 44 Article
  • 2 Review article
  • 1 Short survey

HIV portends a poor prognosis in myelodysplastic syndromes

Kaner, J. D., Thibaud, S., Jasra, S., Wang, Y., Janakiram, M., Sharma, A., Sridharan, A., Elias, H., Polineni, R., Assal, A., Weiss, L., Braunschweig, I., Steidl, U., Pradhan, K., Shastri, A., Chaitowitz, M., Zingman, B., Will, B., Mantzaris, I. & Verma, A., Jan 1 2019, In : Leukemia and Lymphoma.

Research output: Contribution to journalArticle

Myelodysplastic Syndromes
Data Mining

Mechanisms and therapeutic prospects of thrombopoietin receptor agonists

Bussel, J., Kulasekararaj, A., Cooper, N., Verma, A., Steidl, U., Semple, J. W. & Will, B., Oct 2019, In : Seminars in Hematology. 56, 4, p. 262-278 17 p.

Research output: Contribution to journalReview article

Thrombopoietin Receptors
Aplastic Anemia
Immunosuppressive Agents
Idiopathic Thrombocytopenic Purpura

Phase II study of the ALK5 inhibitor galunisertib in very low-, low-, and intermediate-risk myelodysplastic syndromes

Santini, V., Valcarcel, D., Platzbecker, U., Komrokji, R. S., Cleverly, A. L., Lahn, M. M., Janssen, J., Zhao, Y., Chiang, A., Giagounidis, A., Guba, S. C., Gueorguieva, I., Girvan, A. C., Da Silva Ferreira, M., Bhagat, T. D., Pradhan, K., Steidl, U., Sridharan, A., Will, B. & Verma, A., Dec 1 2019, In : Clinical Cancer Research. 25, 23, p. 6976-6985 10 p.

Research output: Contribution to journalArticle

Myelodysplastic Syndromes
Cell Differentiation
Stem Cells
1 Citation (Scopus)

Proteome-wide analysis of chaperone-mediated autophagy targeting motifs

Kirchner, P., Bourdenx, M., Madrigal-Matute, J., Tiano, S., Diaz, A., Bartholdy, B. A., Will, B. & Cuervo, A. M., May 1 2019, In : PLoS biology. 17, 5, p. e3000301

Research output: Contribution to journalArticle

Open Access
Amino Acid Motifs
6 Citations (Scopus)

Antisense STAT3 inhibitor decreases viability of myelodysplastic and leukemic stem cells

Shastri, A., Choudhary, G., Teixeira, M., Gordon-Mitchell, S., Ramachandra, N., Bernard, L., Bhattacharyya, S., Lopez, R., Pradhan, K., Giricz, O., Ravipati, G., Wong, L. F., Cole, S., Bhagat, T. D., Feld, J., Dhar, Y., Bartenstein, M., Thiruthuvanathan, V. J., Wickrema, A., Hilda Ye, B. & 13 others, Frank, D. A., Pellagatti, A., Boultwood, J., Zhou, T., Kim, Y., Robert MacLeod, A., Epling-Burnette, P. K., Ye, M., McCoon, P., Woessner, R., Steidl, U., Will, B. & Verma, A., Dec 3 2018, In : Journal of Clinical Investigation. 128, 12, p. 5489-5504 16 p.

Research output: Contribution to journalArticle

Open Access
Myelodysplastic Syndromes
Stem Cells
Acute Myeloid Leukemia
Myeloid Progenitor Cells
Antisense Oligonucleotides